SARS-CoV-2 RNA (COVID-19), Qualitative NAAT : 39448

Test Code
QCOVD or 39448


Alias/See Also
COVID19, Novel Coronavirus, nCOV, Wuhan, Coronavirus


CPT Codes
87635

Instructions
Each COVID-19 specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag.


Transport Container
Preferred Specimen
 
One (1) nasopharyngeal(NP) swab collected in a multi microbe media (M4, M4RT, M5, M6), VCM (UTM) medium (green-top) tube, Amies liquid elution swab (ESwab), or equivalent Viral Transport Media (VTM), including saline or PBS
 
Alternative Specimens
 
Upper respiratory specimens such as: One (1) oropharyngeal (OP) swab; combination NP/OP swabs collected together; or an anterior nares specimen (collected using only a foam swab) in a multi microbe media (M4, M4RT, M5, M6), VCM (UTM) medium (green-top) tube, Amies liquid elution swab (ESwab), or equivalent Viral Transport Media (VTM), including saline or PBS
OR
Lower respiratory specimens such as: 0.85 mL bronchoalveolar lavage/wash, nasopharyngeal aspirate/wash, tracheal aspirate, or sputum sample collected in a plastic sterile leak-proof container
 
Minimum Volume
 
1 swab or 0.6 mL


Transport Temperature
Frozen.


Specimen Stability
Room temperature: 5 days; Refrigerated: 5 days; Frozen: Acceptable


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Calcium alginate swabs; Cotton swabs with wooden shaft; Amies liquid or gel transport used for bacterial cultures; Tubes with clot activator; Glass tubes; Snap-cap tubes; 3D printed swabs ;Media with guanidine isothiocyanate (GITC) due to safety concerns


Methodology
Nucleic Acid Amplification Test (NAAT) includes RT-PCR or TMA

Setup Schedule
Monday - Saturday


Report Available
1-3 days (From receipt at performing laboratory)


Limitations
This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.


Reference Range
Not detected


Clinical Significance
The SARS-CoV-2 RNA (COVID-19), Nucleic-acid Amplification Test (NAAT) is a qualitative multi-target molecular diagnostics test that aids in the detection of COVID-19. This test is intended to be performed on respiratory specimens collected from individuals who meet the Centers for Diseases Control and Prevention (CDC) clinical and/or Epidemiological criteria for COVID-19 testing. For details visit: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html


Performing Laboratory
Quest Diagnostics



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.